A man in his late 60s with a history of arterial hypertension, dyslipidaemia and a cerebrovascular accident 20 years ago presented to the emergency department with sudden-onset blurred vision in his ...
Please provide your email address to receive an email when new articles are posted on . The mean time to treatment was 2.5 hours after presentation. Initial outcomes demonstrated significant ...
A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis. A study published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results